Salivary Gland Cancer
📧 Sign up to get email alerts when something new happens for Salivary Gland Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-05-05Clinical Trial Update: Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer [Phase 2]
A Phase 2 trial update for cediranib maleate in patients with recurrent or metastatic head and neck squamous cell carcinoma has completed en…
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer [Phase 2]
A Phase 2 trial evaluating lapatinib ditosylate in patients with metastatic or recurrent head and neck cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2015-04-03Clinical Trial Update: Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors [Phase 2]
A Phase 2 trial evaluating dasatinib for recurrent or metastatic malignant salivary gland tumors has completed, with results posted in 2015.
-
CLINICAL_TRIALS research · 2015-04-03Clinical Trial Update: Investigating the Role of Mucin and Mucin Glycosylating Enzymes in Nasopharyngeal Carcinoma and Salivary Gland Cancer and Their Correlation With Clinical Prognosis
A clinical trial from National Taiwan University Hospital investigates the role of mucins and mucin glycosylating enzymes in nasopharyngeal …
-
CLINICAL_TRIALS trial_result · 2015-03-05Clinical Trial Update: TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck [Phase 1]
Phase 1 trial evaluating the combination of the TLR8 agonist VTX-2337 with cetuximab for locally advanced, recurrent, or metastatic squamous…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trial evaluating the combination of erlotinib and docetaxel in patients with locally advanced, metastatic, or recur…
-
CLINICAL_TRIALS other · 2013-04-24Clinical Trial Update: CO(Mbined Therapy of Malignant) S(Alivary Gland tu)M(Ours With)I(MRT and) c(Arbon Ions): COSMIC [Phase 2]
Phase 2 COSMIC trial evaluating combined radiotherapy using MRT and carbon ions for malignant salivary gland tumors; current status is not d…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [Phase 2]
This document provides an update on a Phase 2 trial of sorafenib for patients with recurrent or metastatic head and neck cancer and indicate…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Trastuzumab in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer [Phase 2]
A Phase 2 trial evaluating trastuzumab in metastatic or recurrent salivary gland cancers has been terminated. The study included histologies…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Bortezomib Followed by the Addition of Doxorubicin at Disease Progression in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma (Cancer) of the Head and Neck [Phase 2]
This Phase 2 trial update examines bortezomib followed by doxorubicin at progression in patients with locally advanced, recurrent, or metast…
-
CLINICAL_TRIALS trial_result · 2012-07-27Clinical Trial Update: Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [Phase 2]
A Phase 2 study of dasatinib in patients with recurrent or metastatic head and neck cancer has completed and posted results.